Blueprint Medicines SG&A Expenses 2014-2024 | BPMC

Blueprint Medicines sg&a expenses for the twelve months ending September 30, 2024 were $0.344B, a 24.02% increase year-over-year.

  • Blueprint Medicines annual sg&a expenses for 2023 were $0.295B, a 24.34% increase from 2022.
  • Blueprint Medicines annual sg&a expenses for 2022 were $0.237B, a 21.55% increase from 2021.
  • Blueprint Medicines annual sg&a expenses for 2021 were $0.195B, a 23.8% increase from 2020.

Blueprint Medicines SG&A Expenses 2014-2024 | BPMC

  • Blueprint Medicines annual sg&a expenses for 2023 were $0.295B, a 24.34% increase from 2022.
  • Blueprint Medicines annual sg&a expenses for 2022 were $0.237B, a 21.55% increase from 2021.
  • Blueprint Medicines annual sg&a expenses for 2021 were $0.195B, a 23.8% increase from 2020.